Olanzapine-Associated Hepatotoxicity in Bipolar Disorder: A Multicenter Real-World Study of Prevalence, Risk Factors, and Outcomes
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-16
DOI: 10.2147/dddt.s598447 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Fang Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China. Hauptthemen laut MEDLINE: Olanzapine, Bipolar Disorder, Chemical and Drug Induced Liver Injury, Antipsychotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
- Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.
- Department of Pharmacy, Guihang Guiyang Hospital, Guiyang, Guizhou, People's Republic of China.
- Department of Pharmacy, Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guangdong, People's Republic of China.
- Department of Pharmacy, The Affiliated Qingdao Third People's Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
- Department of Pharmacy, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, People's Republic of China.
Zitieren
APA
Wang, F., Lai, X., Zhou, S., Lin, J., Xin, H., Tao, Z., Wang, X., Zhang, S., Liu, Z., Tan, H., & Xiong, Y. (2026). Olanzapine-Associated Hepatotoxicity in Bipolar Disorder: A Multicenter Real-World Study of Prevalence, Risk Factors, and Outcomes. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s598447
Vancouver
Wang F, Lai X, Zhou S, Lin J, Xin H, Tao Z, et al. Olanzapine-Associated Hepatotoxicity in Bipolar Disorder: A Multicenter Real-World Study of Prevalence, Risk Factors, and Outcomes. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s598447
BibTeX
@article{Wang2026,
author = {Wang, Fang and Lai, Xin and Zhou, Shihai and Lin, Jiale and Xin, Hao and Tao, Zhengnan and Wang, Xiaolu and Zhang, Sitian and Liu, Zhou and Tan, Huawei and Xiong, Yuanguo},
title = {Olanzapine-Associated Hepatotoxicity in Bipolar Disorder: A Multicenter Real-World Study of Prevalence, Risk Factors, and Outcomes},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--16},
doi = {10.2147/dddt.s598447}
}
EUVIMED